Eric Sibley, M.D., Ph.D.
Academic Appointments
- Associate Professor, Pediatrics - Gastroenterology
Contact Information
-
Clinical Offices
Medicine Specialties Clinic 730 Welch Rd 2nd Floor Palo Alto, CA 94304 Tel Work (650) 736-7642Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Tel (650) 723-5070Administrative Contact Carmen Kimberling Administrative Assistant Email Tel Work 650-725-1029Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Gastroenterology/Nutrition/Hepatology, Pediatric
- Pediatric Gastroenterology
Administrative Appointments
- Editor-In-Chief, Journal of Pediatric Gastroenterology and Nutrition (2006 - 2011)
- Chair/Vice-Chair, Growth, Development and Aging Section, American Gastroenterology Association (2007 - 2011)
- Senator, School of Medicine Faculty Senate (2009 - 2012)
- Associate Director (Research), Stanford Pediatric Gastroenterology Training Program (2004 - present)
- Member, Clinical and Integrative Gastrointestinal Pathobiology Study Section, NIH (2004 - 2007) View All 6administrative appointments of Eric Sibley
Honors and Awards
- Young Faculty Investigator Award, North American Society for Pediatric Gastroenterology and Nutrition (1998)
- Named Investigator Award, Stanford Digestive Disease Center (2002-2003)
- Council, elected, Society for Pediatric Research (2005-2008)
- Council, elected, American Gastroenterology Association (2007-2011)
Professional Education
| Board Certification: | Pediatric Gastroenterology, American Board of Pediatrics (1997) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1996) |
| Residency: | Harbor-UCLA Medical Center, CA (1993) |
| Internship: | Harbor-UCLA Medical Center, CA (1991) |
| Medical Education: | Johns Hopkins University School of Medicine, MD (1990) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Scientific Focus
Current Research Interests
Transcriptional Regulation of Intestine-Specific Gene Expression during Gut Development and Maturation.
The mammalian gastrointestinal tract matures from a primitive tube into morphologically and functionally distinct regions during development. The mature small intestine functions in the digestion and absorption of ingested nutrients. Expression of several nutrient hydrolases is spatially restricted to distinct segments along the cephalo-caudal axis of the small intestine and is temporally regulated during postnatal maturation. Intestinal lactase, the hydrolase responsible for the digestion of lactose in milk, is expressed at highest levels in the jejunal segment of the small intestine shortly after birth and then declines dramatically just prior to weaning in most mammals.
Our research is directed towards defining the mechanisms regulating the spatial and temporal restriction of lactase gene expression during intestinal development. The normal maturational decline in lactase enzymatic activity is correlated with a decline in lactase messenger RNA levels and is transcriptionally regulated. We are currently identifying maturation-specific lactase gene cis elements and characterizing the nuclear proteins interacting with those elements in cell culture and transgenic animals. We seek to define the interactions of the lactase gene elements and nuclear factors involved in mediating transcriptional control. The overall goal is to relate these lactase control mechanisms to the broader pathways specifying acquisition of a small intestinal phenotype. We are also investigating gene transfer methods to deliver specific genes to the intestine.
Publications
- Pdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells. Am J Physiol Gastrointest Liver Physiol. 2009; (6): G1126-37
- Microtome-free 3-dimensional confocal imaging method for visualization of mouse intestine with subcellular-level resolution. Gastroenterology. 2009; (2): 453-65
- Transient cytochalasin-D treatment induces apically administered rAAV2 across tight junctions for transduction of enterocytes. J Gen Virol. 2008; (Pt 12): 3004-8
- Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma. Cancer Biol Ther. 2008; (2): 303-9
- Spatio-temporal patterns of intestine-specific transcription factor expression during postnatal mouse gut development. Gene Expr Patterns. 2006; (4): 426-32
